Double-Blind, Crossover, Placebo-Controlled Evaluation of the Effect of Levalbuterol (R-Albuterol) [levosalbutamol] on Allergen Induced Airway Inflammation In Subjects With Atopic Asthma.
Phase of Trial: Phase II
Latest Information Update: 01 Mar 2011
At a glance
- Drugs Levosalbutamol; S-salbutamol
- Indications Allergic asthma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 01 Mar 2011 Actual end date changed from Nov 2008 to Nov 2009 as reported by ClinicalTrials.gov.
- 07 Jul 2009 Actual end date (Nov 2008) added as reported by ClinicalTrials.gov.